You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Intermingling Genomics and Ovarian Cancer Treatment Decisions

  • Authors: Ursula A. Matulonis, MD; Floor J. Backes, MD
  • CME / ABIM MOC Released: 9/20/2023
  • Valid for credit through: 9/20/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for oncologists, gynecologists, obstetricians, pathologists, and other clinicians who treat patients with OC.

The goal of this activity is for learners to be better able to consider all aspects of a patient's condition prior to initiating therapy for patients with OC through in-depth case discussions.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Impact of genetic mutations in guiding treatment decisions for patients with OC
    • Clinical trial data associated with PARP inhibitor-based treatment options for patients with OC
  • Have greater competence related to
    • Selecting treatment based on genetic mutations for patients with OC


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


  • Ursula A. Matulonis, MD

    Professor of Medicine
    Harvard Medical School
    Chief, Division of Gynecologic Oncology
    Brock-Wilson Family Chair
    Dana-Farber Cancer Institute
    Boston, Massachusetts


    Ursula A. Matulonis, MD, has the following relevant financial relationships:
    Consultant or advisor for: Agenus; AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; CureLab; Eisai Inc.; GlaxoSmithKline; Merck & Co., Inc.; MorphoSys; NextCure; Novartis Pharmaceuticals; Ovarian Cancer Research Alliance; Pfizer, Inc.; ProfoundBio; Trillium
    Other: DSMB participation: Alkermes, Inc.; Symphogen

  • Floor J. Backes, MD

    Professor of Gynecologic Oncology
    The Ohio State University
    James Cancer Hospital
    Columbus, Ohio 


    Floor J. Backes, MD, has the following relevant financial relationships:
    Consultant or advisor for: Agenus; AstraZeneca; Clovis Oncology; Eisai Inc.; GlaxoSmithKline; ImmunoGen; Merck & Co., Inc.; Myriad
    Research funding from: Clovis Oncology; Eisai Inc.; ImmunoGen; Merck & Co., Inc.


  • Amy Furedy, RN, OCN

    Medical Education Director, Medscape, LLC


    Amy Furedy, RN, OCN, has no relevant financial relationships.

  • Yoji Yamaguchi, MA, ELS

    Scientific Content Manager, Medscape, LLC


    Yoji Yamaguchi, MA, ELS, has no relevant financial relationships.

Compliance Reviewer

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per 5-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Intermingling Genomics and Ovarian Cancer Treatment Decisions

Authors: Ursula A. Matulonis, MD; Floor J. Backes, MDFaculty and Disclosures

CME / ABIM MOC Released: 9/20/2023

Valid for credit through: 9/20/2024, 11:59 PM EST


Educational Impact Challenge

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

  • Print